CHEK2 and hematologic disorder: Overall, cases who were PV carriers across these three genes had an elevated frequency of positive family history of hematologic malignancies compared to non-carrier cases (20.6% vs. 14.7%, p = 0.06), which was largely driven by the positive family history frequency of PV in CHEK2 (22.7%).